Safety Lancet Market

Safety Lancet Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Safety Lancet Market place for the forecast 2020– 2025.

Enhancing laws related to medical device will power the growth of safety lancet market. Regulatory authorities in developed and developing nations frame specific laws for medical devices to make sure that superior-quality medical machines are created and promoted.

Scope of The Report:

Lancets are being employed for glucose/diabetes test, heel-stick screening tests, tests in infants, as well as for severely burned patients or scarred emergency patients. The factors powering the demand of lancets comprise increasing occurrence of diabetes, growing incidence rate of non-contagious and contagious diseases, and increasing preference towards home diagnostics and home care. On the other hand, the risk related to blood transfusion is predicted to hamper the demand of the product during the coming period.

The global lancet market by type has been divided into personal lancet and safety lancet. Safety lancets can be further segmented into pressure activated safety lancets, push-button safety lancets, and side button safety lancets. By end user, the market is divided into the diagnostic centers & pathology laboratories, hospitals & clinics, research and academic laboratories, home diagnostics, and others. The hospitals & clinics section had a major share in the market. The hospitals and clinics section is predicted to lead the safety lancets market. The major share of this section is primarily credited to the increasing occurrence of infectious diseases that need blood testing for treatment & diagnosis and the availability of a large patient pool.

Safety Lancet Manufacturers:

The major players included in the global safety lancet market forecast are,

• Bayer AG
• Terumo Corporation
• Sarstedt AG & Co.
• HTL-STREFA S.A.
• Abbott Laboratories
• Becton
• Dickinson and Company
• Greiner Bio-One International GmbH
• F. Hoffmann-La Roche Ltd
• Improve Medical Instruments Co. Ltd.

Safety Lancet Key Market Segments:

by Type: Safety Lancets, Personal Lancets

by Application: Glucose Testing, Hemoglobin Testing, Coagulation Testing, Other Applications

The Safety Lancet Market Is Predicted To See Lucrative Development Over The Coming Years Due To The Increasing Occurrence Of Non-Contagious Diseases

The safety lancet market is predicted to see lucrative development over the coming years due to the increasing occurrence of non-contagious diseases such as dyslipidemia, diabetes, and hyperlipidemia all over the globe. According to the CDC, 1.5 million new instances of diabetes were detected amongst the US aged population. Abovementioned factors paired with the rising inclination toward home healthcare devices will power the growth of the market.

Enhancing laws related to medical device will power the growth of safety lancet market. Regulatory authorities in developed and developing nations frame specific laws for medical devices to make sure that superior-quality medical machines are created and promoted. Hence, a favorable regulatory situation positively affects the safety lancet market development. On the other hand, lack of awareness related to lancets in underdeveloped and developing nations might impact the market growth to some level.

Europe Had The Biggest Share Of The Global Safety Lancet Market Due To The Rise In Insulin Users

Europe had the biggest share of the global safety lancet market due to the increasing need and demand for safe blood glucose tests in clinics, hospitals, and diagnostics centers and the rise in insulin users. The Americas had a considerable share in the global safety lancet market due to the increasing need for a diabetes diagnosis and the growth in the occurrence of diabetes. Asia Pacific was the quickest developing area in the global market and added up for a huge market share in the global market. The development in this area is credited to the low labor cost and low manufacturing cost in the region. In addition to this, the Middle East and Africa displayed the least development due to lack of adequate healthcare spending and low per capita income.

Market by Regional Analysis

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA